Long-term opioid use does not increase risk of developing Alzheimer's disease, according to a study published in Pain Medicine.
GLP-1s
Danville, Pa.-based Geisinger Health System and pharmaceutical company Boehringer Ingelheim joined forces to create a predictive model to improve health outcomes for Type 2 diabetes patients, the companies announced Sept. 25.
Bloomfield, Conn.-based Cigna will remove OxyContin from its covered drug list Jan. 1.
In 2015, opioids accounted for more than two-thirds of all drug overdose deaths in the United States -- 15.6 percent more than the previous year -- and drug overdose deaths nearly tripled between 1999 and 2014.
A third of Americans check the cost of a prescription before filling: Prescription drug adherence lags among Americans with more formal education, higher income
Advertisement
Intermountain Precision Genomics, a St. George, Utah-based lab of Salt Lake City-based Intermountain Healthcare, launched the DNA-based RxMatch Anti-Depressant Panel Sept. 5.
The opioid epidemic is a complex issue that will require a multipronged approach to address, according to Doug Nemecek, MD, MBA, CMO of behavioral health for Bloomfield, Conn.–based Cigna.
The number of Americans dying from opioid overdoses is staggering. In 2015, a record 52,404 people in the U.S. died from drug overdoses. The rise in deaths was largely driven the 33,000 deaths attributable to opioids — a record number,…
Millennials are half as likely as baby boomers to use opioids for pain relief, a new survey, commissioned by the American Society of Anesthesiologists, shows.
Prescient Medicine created a genetic test to assess individual risk of opioid addiction, according to a study published in Annals of Clinical & Laboratory Science.